Unstable Angina Pectoris: Clinical Trials

9 trials for Unstable Angina Pectoris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 7, Unknown 2

Follow Unstable Angina Pectoris: new trials by email Literature Review of Unstable Angina Pectoris trials Research Report on Unstable Angina Pectoris

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
Ticagrelor 90 mg, Ticagrelor 45 mg, Aspirin - Unstable Angina Pectoris, Coronary Stent Implantation
Phase 4UnknownXiaofan Wu20362018-08-072018-12-24
Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
Crushed ticagrelor followed by morphine, Crushed ticagrelor, morphine,naloxone - Unstable Angina Pectoris
Phase 4CompletedCollegium Medicum w Bydgoszczy302016-10-012019-04-01
Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
Crushed ticagrelor followed by morphine, Crushed ticagrelor, morphine,metoclopramide - Unstable Angina Pectoris
Phase 4CompletedCollegium Medicum w Bydgoszczy322016-07-012019-04-01
Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study
Pulverized ticagrelor sublingually, Pulverized ticagrelor orally, Integral ticagrelor - Unstable Angina Pectoris
Phase 4CompletedCollegium Medicum w Bydgoszczy492015-09-012016-10-19
Danhong Injection in the Treatment of Unstable Angina Pectoris
Danhong injection, Standard medical care, Placebo - Unstable Angina Pectoris
Phase 4CompletedChina Academy of Chinese Medical Sciences1602013-12-012017-12-02
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
Atorvastatin, Statin - Non-ST Segment Elevation Myocardial Infarction, Unstable Angina Pectoris
Phase 4CompletedPeking University First Hospital28842010-06-012013-04-30
Small Coronary Artery Treated by TAXUS Liberté Registry in Japan
TAXUS Liberté paclitaxel-eluting coronary stent system - Stable Angina Pectoris, Unstable Angina Pectoris
Phase 4UnknownSociety for Advancement of Coronary Intervention Research2502009-04-012010-06-10
The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente
Endeavor Resolute (Biolinx-based Zotarolimus-eluting stent), Xience V (Everolimus-eluting stent) - Coronary Artery Disease, Angina Pectoris
Phase 4CompletedFoundation of Cardiovascular Research and Education Enschede13912008-06-012015-07-28
Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction
Sitagliptin - Myocardial Infarction, Unstable Angina Pectoris
Phase 4CompletedKarolinska Institutet852008-05-012021-02-12

Narrower conditions

Angina, Unstable (9)  ·  Angina, Stable (2)  ·  Coronary Artery Disease (2)  ·  Angina Pectoris (1)  ·  Atherosclerosis (1)  ·  Coronary Restenosis (1)  ·  Coronary Stenosis (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)  ·  Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (9)  ·  Chest Pain (9)  ·  Heart Diseases (9)  ·  Myocardial Ischemia (9)  ·  Neurologic Manifestations (9)  ·  Pain (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (9)  ·  Vascular Diseases (9)  ·  Angina Pectoris (8)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Coronary Disease (2)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)

Interventions

Ticagrelor (4)  ·  Morphine (2)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Fluvastatin (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Metoclopramide (1)  ·  Naloxone (1)  ·  Pravastatin (1)  ·  Simvastatin (1)  ·  Sitagliptin Phosphate (1)  ·  danhong (1)

Sponsors

Collegium Medicum w Bydgoszczy (3)  ·  China Academy of Chinese Medical Sciences (1)  ·  Foundation of Cardiovascular Research and Education Enschede (1)  ·  Karolinska Institutet (1)  ·  Peking University First Hospital (1)  ·  Society for Advancement of Coronary Intervention Research (1)  ·  Xiaofan Wu (1)

Countries

China (3)  ·  Poland (3)  ·  Japan (1)  ·  Netherlands (1)  ·  Sweden (1)

Top investigators

Jacek Kubica, MD., PhD. (3)  ·  C. von Birgelen, MD,PhD,Prof (1)  ·  Kenya Nasu, MD (1)  ·  Xian Wang, M.D. (1)  ·  Xiao-xi Du, Professor (1)  ·  Xiaofan Wu (1)  ·  Yong Huo, MD (1)  ·  Yuji Oikawa, MD (1)  ·  Zhong Wang, M.D., Ph.D. (1)

Results publications

PMID 22341737, PMID 22456695, PMID 22581199, PMID 23359390, PMID 23602769, PMID 24585502, PMID 25339110, PMID 28114618, PMID 34732357, PMID 35641327, PMID 37619976, PMID 37745109, PMID 38598970, PMID 39959922, PMID 40687396